🔍 See what insiders are buying — free 7-day trial, no credit card required.
Get started →
42Score
DipBuster Score™
$302.47
+$1.05 (+0.35%)
Live price · Source: Yahoo
52-Week Position
$267.00
29% of range
$389.33
Beta
0.781
Low vol
Dividend
—
no income
Mkt Cap
N/A
total value
Mkt CapN/A
P/EN/A
DividendNone
Beta0.781
52W High$389.33
52W Low$267.00
DipBuster Brief
Key signals at a glance
Zone: Buy Zone
Neutral
Mid-Range Position (29% of 52-Week Range)
The stock sits in the middle of its annual range — no extreme dip opportunity, but also not overextended.
Neutral
Earnings Data Unavailable
P/E ratio could not be determined — this is common for early-stage, loss-making, or recently-listed companies.
Valuation
P/E Ratio—
Mkt CapN/A
52W Position29% of range
EV/EBITDA—
Cash Flow
FCF Yield—
FCF / Share
Op. Cash Flow—
Margins
Gross Margin—
Op. Margin—
Net Margin—
Balance Sheet
Cash—
Total Debt—
Net Cash—
Dividend
Yield—
Annual / shNone
Beta0.781
🔒
FCF, margins & balance sheet data are hidden — create a free account to see them.
🕵️ Insiders
📊 Valuation
💰 Dividends
📰 News
🤖 AI Analysis
Recent director dealings and insider transactions at Stryker Corporation (SYK), from SEC Form 4 filings. Open-market buys by directors spending their own money are one of the strongest signals in investing.
| Date | Insider | Type | Shares |
|---|---|---|---|
| 2026-09-24 | Wells Preston Wendell | SELL | 109 |
| 2026-09-22 | Wells Preston Wendell | SELL | 962 |
| 2026-08-21 | Crotty Dylan Bram | SELL | 441 |
| 2026-08-19 | Stryker Ronda E | SELL | 805 |
| 2026-08-19 | Stryker Ronda E | SELL | 3,852 |
| 2026-08-19 | Stryker Ronda E | SELL | 3,274 |
| 2026-08-19 | Stryker Ronda E | SELL | 16,612 |
| 2026-08-19 | Stryker Ronda E | SELL | 10,812 |
| 2026-08-19 | Stryker Ronda E | SELL | 11,257 |
| 2026-08-19 | Stryker Ronda E | SELL | 2,308 |
Valuation
P/E RatioN/A
Market CapN/A
Beta0.781
Dividend/yrNone
52W High$389.33
52W Low$267.00
52-Week Range
$267.00Now$389.33
29% through annual range
From 52W High−22.3%
From 52W Low+13.3%
📖 Plain English Summary
Stryker Corporation is at 29% of its 52-week range. Beta 0.781 — tends to move less than the market.
🏦 Analyst Price Target
Loading…
🎯 Analyst Revenue & EPS Estimates
Loading estimates…
🔄 Peer Comparison
Loading peers…
Loading dividend data…
Latest news for SYK
🟢 Bullish
⬜ Neutral
🔴 Bearish
🤖
DipBuster AI Analysis — SYK
Heuristic · balance sheet, insider filings, price data, academic research
Stryker Corporation — DipBuster Score 42/100
Graham value assessment, NCAV analysis, price zones...
Insider signals, cluster detection, risk factors...
Track Stryker Corporation free
Add SYK to a watchlist, set insider-buy and price alerts, and get the full financial picture — free account, no card.
Sponsored · FCA Regulated Broker
Hargreaves Lansdown
UK's #1 investment platform. ISA, SIPP, GIA. FCA regulated since 1981.
Capital at risk. Your investments can go down as well as up. Disclaimer
DipBuster Score™ Breakdown
Value & P/E
0/30
Dip Position
28/25
Momentum & Volume
9/25
Quality & Size
5/10
Insider Activity
0/10
🎯 Dip Buyer Signal
23
/100 · NEUTRAL
dip depth
23/25
oversold rsi
0/25
mean reversion
0/15
insider zone
0/25
capitulation
0/10
Technical signal only. Not financial advice.
Quick Take
🟡
Watch
DipBuster Score: 42/100
📊
Run a full check in the AI analysis tab for a deeper look.
Company Profile
Stryker Corporation functions as a prominent medical technology enterprise, with its operations structured across two main divisions. The Orthopaedics and Spine segment specializes in providing implants for joint replace…
Sector
Healthcare
Market
🇺🇸 US
CEO
Kevin A. Lobo
Staff
56,000 employees
Website